Sandbox g19: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) m (→Brain abscess) |
Gerald Chi- (talk | contribs) mNo edit summary |
||
Line 3: | Line 3: | ||
* Empiric antimicrobial therapy | * Empiric antimicrobial therapy | ||
:* Brain abscess in otherwise healthy patients | :* Brain abscess in otherwise healthy patients | ||
::* Preferred regimen | ::* Preferred regimen | ||
* [[Cefotaxime]] 8–12 g/day q4–6h {{or}} [[Ceftriaxone]] 4 g/day q12h {{and}} [[Metronidazole]] 30 mg/kg/day q6h | :::* [[Cefotaxime]] 8–12 g/day q4–6h {{or}} [[Ceftriaxone]] 4 g/day q12h {{and}} [[Metronidazole]] 30 mg/kg/day q6h | ||
::* Alternative regimen | ::* Alternative regimen | ||
* [[Meropenem]] 6 g/day q8h | :::* [[Meropenem]] 6 g/day q8h | ||
:* Brain abscess with comorbidities | :* Brain abscess with comorbidities |
Revision as of 05:01, 5 June 2015
Brain abscess
- Empiric antimicrobial therapy
- Brain abscess in otherwise healthy patients
- Preferred regimen
- Cefotaxime 8–12 g/day q4–6h OR Ceftriaxone 4 g/day q12h AND Metronidazole 30 mg/kg/day q6h
- Alternative regimen
- Meropenem 6 g/day q8h
- Brain abscess with comorbidities